1. Home
  2. TMDX vs RDY Comparison

TMDX vs RDY Comparison

Compare TMDX & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • RDY
  • Stock Information
  • Founded
  • TMDX 1998
  • RDY 1984
  • Country
  • TMDX United States
  • RDY India
  • Employees
  • TMDX N/A
  • RDY N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • TMDX Health Care
  • RDY Health Care
  • Exchange
  • TMDX Nasdaq
  • RDY Nasdaq
  • Market Cap
  • TMDX 2.3B
  • RDY 2.1B
  • IPO Year
  • TMDX 2019
  • RDY N/A
  • Fundamental
  • Price
  • TMDX $123.56
  • RDY $15.23
  • Analyst Decision
  • TMDX Buy
  • RDY Strong Buy
  • Analyst Count
  • TMDX 10
  • RDY 2
  • Target Price
  • TMDX $127.33
  • RDY $16.95
  • AVG Volume (30 Days)
  • TMDX 830.9K
  • RDY 1.7M
  • Earning Date
  • TMDX 07-30-2025
  • RDY 07-28-2025
  • Dividend Yield
  • TMDX N/A
  • RDY 0.63%
  • EPS Growth
  • TMDX N/A
  • RDY 1.47
  • EPS
  • TMDX 1.41
  • RDY 0.79
  • Revenue
  • TMDX $488,227,000.00
  • RDY $3,809,801,863.00
  • Revenue This Year
  • TMDX $34.07
  • RDY $10.24
  • Revenue Next Year
  • TMDX $20.76
  • RDY N/A
  • P/E Ratio
  • TMDX $87.63
  • RDY $19.24
  • Revenue Growth
  • TMDX 64.43
  • RDY 16.61
  • 52 Week Low
  • TMDX $55.00
  • RDY $12.26
  • 52 Week High
  • TMDX $177.37
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 45.61
  • RDY 55.04
  • Support Level
  • TMDX $139.31
  • RDY $15.16
  • Resistance Level
  • TMDX $145.50
  • RDY $16.17
  • Average True Range (ATR)
  • TMDX 5.88
  • RDY 0.20
  • MACD
  • TMDX -2.71
  • RDY -0.07
  • Stochastic Oscillator
  • TMDX 12.94
  • RDY 39.74

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: